Collagen is the core structural protein present in cartilage, providing tensile strength and toughness to the tissue. However, some common joint conditions can activate an autoimmune response against the body’s own endogenous type II collagen, impacting joint health. Collavant™ n2 is a next generation collagen for joint health innovation that helps regulate the body’s response to endogenous type II collagen and reduces its degradation. Endorsed by multiple scientific studies, it is highly efficacious at a low dose and supported by Bioiberica’s 20+ years’ experience in joint health and mobility innovation.
